123 related articles for article (PubMed ID: 38016434)
1. Growth and Treatment in Congenital Adrenal Hyperplasia: An Observational Study from Diagnosis to Final Height.
Gidlöf S; Hogling DE; Lönnberg H; Ritzén M; Lajic S; Nordenström A
Horm Res Paediatr; 2023 Nov; ():. PubMed ID: 38016434
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
[TBL] [Abstract][Full Text] [Related]
4. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[TBL] [Abstract][Full Text] [Related]
5. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C
Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
[TBL] [Abstract][Full Text] [Related]
6. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z; Akbuğa S; Cetinkaya E; Ocal G; Berberoğlu M; Evliyaoğlu O; Adiyaman P
Turk J Pediatr; 2009; 51(6):539-44. PubMed ID: 20196386
[TBL] [Abstract][Full Text] [Related]
7. CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency.
Balsamo A; Cicognani A; Baldazzi L; Barbaro M; Baronio F; Gennari M; Bal M; Cassio A; Kontaxaki K; Cacciari E
J Clin Endocrinol Metab; 2003 Dec; 88(12):5680-8. PubMed ID: 14671153
[TBL] [Abstract][Full Text] [Related]
8. Relationship between final height and health outcomes in adults with congenital adrenal hyperplasia: United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE).
Han TS; Conway GS; Willis DS; Krone N; Rees DA; Stimson RH; Arlt W; Walker BR; Ross RJ;
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1547-55. PubMed ID: 24878054
[TBL] [Abstract][Full Text] [Related]
9. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W; Schwarz HP
Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
[TBL] [Abstract][Full Text] [Related]
10. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
11. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
Hoepffner W; Kaufhold A; Willgerodt H; Keller E
Horm Res; 2008; 70(1):42-50. PubMed ID: 18493149
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.
Krone N; Rose IT; Willis DS; Hodson J; Wild SH; Doherty EJ; Hahner S; Parajes S; Stimson RH; Han TS; Carroll PV; Conway GS; Walker BR; MacDonald F; Ross RJ; Arlt W;
J Clin Endocrinol Metab; 2013 Feb; 98(2):E346-54. PubMed ID: 23337727
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Leite FM; Longui CA; Kochi C; Faria CD; Borghi M; Calliari LE; Monte O
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):101-8. PubMed ID: 18345402
[TBL] [Abstract][Full Text] [Related]
14. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C; Improda N; Maggioli C; Capalbo D; Roma S; Porzio O; Salerno M; Cappa M
Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond.
Troger T; Sommer G; Lang-Muritano M; Konrad D; Kuhlmann B; Zumsteg U; Flück CE
J Clin Endocrinol Metab; 2022 Jan; 107(2):e487-e499. PubMed ID: 34599587
[TBL] [Abstract][Full Text] [Related]
16. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
Aycan Z; Ocal G; Berberoglu M; Cetinkaya E; Adiyaman P; Evliyaoglu O
J Pediatr Endocrinol Metab; 2006 Mar; 19(3):245-51. PubMed ID: 16607925
[TBL] [Abstract][Full Text] [Related]
17. Do All Patients with Congenital Adrenal Hyperplasia Need to Be on Hydrocortisone Three Times a Day in Order to Have Normal Growth?
Logan LA; Nebesio TD; Eckert GJ; Eugster EA
Horm Res Paediatr; 2022; 95(5):461-464. PubMed ID: 35649383
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Falhammar H; Filipsson Nyström H; Wedell A; Thorén M
Eur J Endocrinol; 2011 Feb; 164(2):285-93. PubMed ID: 21098686
[TBL] [Abstract][Full Text] [Related]
19. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J; Aldridge S; Thomas M; Cheetham T
J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1019-1022. PubMed ID: 30173205
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
Falhammar H; Filipsson Nyström H; Wedell A; Brismar K; Thorén M
Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
